Safe Handling of Hazardous Drugs: ASCO Standa...

Dr. Jennifer Caswell-Jin and Dr. Michael Hassett join the podcast to introduce the new living guideline, "Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer." As co-chairs of the expert panel, they provide a comprehensive overview of the guidel ...  Afficher plus

Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on ...  Afficher plus

On this episode, we review medication regimens for special patient populations. We start with a quick overview of CYP450 drug-drug interactions. We then discuss safety conerns when starting medications in a patient that is pregnant, is at an increase risk for a bleed, renal im ...

In this podcast, Dr Emma Nash talks to Professor Tony Avery, GP, Professor of Primary Health Care at the University of Nottingham, and National Clinical Director for Prescribing. Key points from the two prescribing safety modules are touched on, in the context of the Medicines Sa ...  Afficher plus

On this episode, we are joined by a fellow MUSC alum, Dr. Andrew Fariello, PharmD. Dr. Fariello is the VP of Global Medical Capabilities in Oncology for AstraZeneca. He discusses his career path starting with his work as a clinical pharmacist through his time with AstraZeneca. ...